Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada
FSD Pharma To Acquire Lucid Psycheceuticals; Transaction Will Involve Issuance Of ~4.5M Class B Share sOf FSD With Deemed Aggregate Purchase Price Of ~$9M
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) (FRA: 0K9) ("FSD Pharma" or the "Company"), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal
